Dentsply Sirona INC Form 4 insider transactions

John C. Fortson, EVP & CFO of DENTSPLY SIRONA Inc., reported multiple transactions in common stock on August 10, 2026.

Andrea L. Frohning, SVP, CHRO of DENTSPLY SIRONA Inc., reported a transaction in 802 shares of common stock on August 7, 2026.

DENTSPLY SIRONA Inc. director Jonathan Jay Mazelsky acquired phantom stock units valued at $10.56 per share, representing a total of 2,841.8303 units.

DENTSPLY SIRONA Inc. reports a Form 4 filing detailing a stock purchase by Director Jonathan Jay Mazelsky.

Director Clyde Hosein acquired 6,500 shares of Dentsply Sirona common stock at a price of $9.985 per share.

DENTSPLY SIRONA Director Brian P. McKeon acquired 10,000 shares of common stock through a trust, signaling confidence.

DENTSPLY SIRONA Inc. reports a significant stock purchase by Director Brian T. Gladden, acquiring over 9,900 shares.

Dentsply Sirona Director Jonathan Jay Mazelsky reported the acquisition of 10,000 shares of common stock.

Betsy D. Holden, a Director at Dentsply Sirona Inc., acquired 10,086 shares of common stock.

Michael J. Barber, a Director at DENTSPLY SIRONA Inc., has acquired 15,175 shares of common stock.

Dentsply Sirona Director Gregory Lucier reported the acquisition and subsequent transfer of equity and options to a family partnership.

Director Donald Zurbay acquired 22,822 restricted stock units in Dentsply Sirona Inc. as part of an equity grant.

Director Janet S. Vergis was granted 22,822 restricted stock units in Dentsply Sirona Inc. as part of an equity compensation award.

Director Leslie F. Varon was granted 22,822 restricted stock units in Dentsply Sirona Inc. as part of an equity compensation award.

Dentsply Sirona Director Brian P. McKeon was granted 28,887 restricted stock units as part of his compensation package.

Director Jonathan Jay Mazelsky was granted 22,822 restricted stock units by Dentsply Sirona Inc. on June 3, 2026.

Dentsply Sirona Director Clyde Hosein was granted 22,822 restricted stock units as part of an equity compensation arrangement.

Dentsply Sirona director Betsy D. Holden was granted 22,822 restricted stock units as part of annual equity compensation.

Director Brian T. Gladden was granted 22,822 restricted stock units in Dentsply Sirona Inc. as part of an equity compensation arrangement.

Dentsply Sirona Director James D. Forbes was granted 28,887 restricted stock units as part of his annual compensation.

Dentsply Sirona director Michael J. Barber was granted 22,822 restricted stock units as part of annual compensation.

DENTSPLY SIRONA Inc. reports a transaction where President, CEO & Member of BOD Daniel T. Scavilla sold 4,095 shares of common stock.

DENTSPLY SIRONA Inc. Director Jonathan Jay Mazelsky acquired 2,644.6402 shares of phantom stock, representing the economic equivalent of common stock, on March 31, 2026.

DENTSPLY SIRONA's President and CEO, Daniel T. Scavilla, acquired 3,554.869 shares of phantom stock under the company's Supplemental Executive Retirement Plan.

DENTSPLY SIRONA's EVP, Chief Commercial Officer, Aldo Denti, acquired 829.396 phantom stock units as part of a 2025 Supplemental Executive Retirement Plan contribution.

DENTSPLY SIRONA's VP, Chief Accounting Officer, Kevin Czerney, increased his beneficial ownership of phantom stock through a Supplemental Executive Retirement Plan contribution.

DENTSPLY SIRONA's VP, Chief Accounting Officer, Kevin Czerney, received grants of 13,690 Restricted Stock Units and 10,400 stock options.

DENTSPLY SIRONA's SVP and CHRO, Andrea L. Frohning, received an equity award comprising Restricted Stock Units and stock options.

DENTSPLY SIRONA's EVP, Chief Commercial Officer, Aldo Mariano Roberto Denti, received 59,524 Restricted Stock Units and 270,200 stock options.

DENTSPLY SIRONA's President and CEO, Daniel T. Scavilla, received substantial equity awards, including Restricted Stock Units and stock options, vesting over three years.